v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities        
Net loss $ (8,217) $ (10,561) $ (20,040) $ (21,770)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation 100 100 82 106
Amortization of right-of-use assets, operating leases     490 453
Non-cash interest expense     0 219
Amortization of debt discount     128 35
Change in fair value of warrant liabilities (2,483) 859 (1,499) 1,366
Stock-based compensation     1,803 1,227
Changes in operating assets and liabilities:        
Prepaid expenses and other current assets     (1,257) 1,387
Other long-term prepaid assets     (55) 0
Accounts payable     167 2,827
Accrued expenses     863 (3,309)
Deferred research obligation     0 (1,169)
Operating lease liabilities     (492) (441)
Net cash used in operating activities     (19,810) (19,069)
Cash flows from financing activities        
Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs     24,420 2,851
Proceeds from the exercise of common warrants     0 343
Proceeds from issuance of common stock and common warrants from the January 2025 Offering, net of issuance costs     0 9,143
Proceeds from the June 2025 Promissory Note, net of issuance costs     0 9,866
Proceeds from the exercise of stock options     117 57
Net cash provided by financing activities     24,537 22,260
Effect of foreign currency on cash and cash equivalents     1 105
Net increase in cash and cash equivalents     4,728 3,296
Cash, cash equivalents and restricted cash at the beginning of the period     19,267 19,492
Cash, cash equivalents, and restricted cash at the end of the period 23,995 22,788 23,995 22,788
Components of cash and cash equivalents, and restricted cash        
Cash and cash equivalents 23,480 22,088 23,480 22,088
Restricted cash 515 700 515 700
Total cash, cash equivalents and restricted cash $ 23,995 $ 22,788 23,995 22,788
Supplemental disclosure of noncash investing and financing activities:        
Fair value of common stock warrants upon settlement     0 373
Fair value of common warrants issued with January 2025 Offering     0 9,719
Fair value of common warrants issued with June 2025 Promissory Note     0 641
Conversion of Convertible Note and interest into equity     $ 0 $ 20,176